Connection

RU CHEN to Cell Line, Tumor

This is a "connection" page, showing publications RU CHEN has written about Cell Line, Tumor.
Connection Strength

0.527
  1. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome. BMC Cancer. 2019 Jun 24; 19(1):617.
    View in: PubMed
    Score: 0.098
  2. Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer. Sci Rep. 2017 08 11; 7(1):7950.
    View in: PubMed
    Score: 0.086
  3. Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma. Lab Invest. 2015 Jan; 95(1):43-55.
    View in: PubMed
    Score: 0.071
  4. SCP phosphatases suppress renal cell carcinoma by stabilizing PML and inhibiting mTOR/HIF signaling. Cancer Res. 2014 Dec 01; 74(23):6935-46.
    View in: PubMed
    Score: 0.071
  5. Tissue proteomics in pancreatic cancer study: discovery, emerging technologies, and challenges. Proteomics. 2013 Feb; 13(3-4):710-21.
    View in: PubMed
    Score: 0.063
  6. miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res. 2012 Jul 15; 72(14):3631-41.
    View in: PubMed
    Score: 0.060
  7. Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin. Mol Cell Biol. 2004 Dec; 24(24):10558-72.
    View in: PubMed
    Score: 0.036
  8. X-aptamers targeting Thy-1 membrane glycoprotein in pancreatic ductal adenocarcinoma. Biochimie. 2021 Feb; 181:25-33.
    View in: PubMed
    Score: 0.027
  9. Unexpected gain of function for the scaffolding protein plectin due to mislocalization in pancreatic cancer. Proc Natl Acad Sci U S A. 2013 Nov 26; 110(48):19414-9.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.